Li W, Xu G, Chai G, Ball A, Zhang Q, Kutryk M
Sci Rep. 2025; 15(1):6738.
PMID: 40000897
PMC: 11861593.
DOI: 10.1038/s41598-025-91100-1.
Yang Y, Cheng H
Biomolecules. 2024; 14(11).
PMID: 39595541
PMC: 11592034.
DOI: 10.3390/biom14111364.
Agnihotri R, Gaur S, Bhat S
J Int Soc Prev Community Dent. 2024; 14(3):180-191.
PMID: 39055291
PMC: 11268527.
DOI: 10.4103/jispcd.jispcd_3_24.
Rasmi Y, Mohamed Y, Alipour S, Ahmed S, Abdelmajed S
J Diabetes Metab Disord. 2024; 23(1):39-47.
PMID: 38932869
PMC: 11196424.
DOI: 10.1007/s40200-023-01317-y.
Sangali P, Abdullahi S, Nosrati M, Khosravi-Asrami O, Mahrooz A, Bagheri A
J Diabetes Metab Disord. 2024; 23(1):1101-1106.
PMID: 38932834
PMC: 11196532.
DOI: 10.1007/s40200-024-01391-w.
Exploring early DNA methylation alterations in type 1 diabetes: implications of glycemic control.
cugalj Kern B, Kovac J, Sket R, Tesovnik T, Jenko Bizjan B, Galhardo J
Front Endocrinol (Lausanne). 2024; 15:1416433.
PMID: 38904047
PMC: 11188314.
DOI: 10.3389/fendo.2024.1416433.
Heterogeneity and Differentiation of the Human Arterial Tree: Focus on microRNA Expression in Vascular Disease.
Ciavarella C, Motta I, Capri M, Gargiulo M, Pasquinelli G
Biomolecules. 2024; 14(3).
PMID: 38540762
PMC: 10967886.
DOI: 10.3390/biom14030343.
MicroRNAs Associated with a Bad Prognosis in Acute Myeloid Leukemia and Their Impact on Macrophage Polarization.
Jimbu L, Mesaros O, Joldes C, Neaga A, Zaharie L, Zdrenghea M
Biomedicines. 2024; 12(1).
PMID: 38255226
PMC: 10813737.
DOI: 10.3390/biomedicines12010121.
Regulatory Roles of MicroRNAs in the Pathogenesis of Metabolic Syndrome.
Rahman M, Islam M, Ripon M, Islam M, Hossain M
Mol Biotechnol. 2023; 66(7):1599-1620.
PMID: 37393414
DOI: 10.1007/s12033-023-00805-z.
A Review of micro RNAs changes in T2DM in animals and humans.
Afsharmanesh M, Mohammadi Z, Mansourian A, Jafari S
J Diabetes. 2023; 15(8):649-664.
PMID: 37329278
PMC: 10415875.
DOI: 10.1111/1753-0407.13431.
miRNA deregulation and relationship with metabolic parameters after Mediterranean dietary intervention in BRCA-mutated women.
De Summa S, Traversa D, Daniele A, Palumbo O, Carella M, Stallone R
Front Oncol. 2023; 13:1147190.
PMID: 37081976
PMC: 10110888.
DOI: 10.3389/fonc.2023.1147190.
Association of MicroRNA-146a with Type 1 and 2 Diabetes and their Related Complications.
Ghaffari M, Razi S, Zalpoor H, Nabi-Afjadi M, Mohebichamkhorami F, Zali H
J Diabetes Res. 2023; 2023:2587104.
PMID: 36911496
PMC: 10005876.
DOI: 10.1155/2023/2587104.
Association between diabetes and cancer. Current mechanistic insights into the association and future challenges.
Rojas A, Schneider I, Lindner C, Gonzalez I, Morales M
Mol Cell Biochem. 2022; 478(8):1743-1758.
PMID: 36565361
DOI: 10.1007/s11010-022-04630-x.
Potential role of microRNAs in selective hepatic insulin resistance: From paradox to the paradigm.
Palihaderu P, Mendis B, Premarathne J, Dias W, Yeap S, Ho W
Front Endocrinol (Lausanne). 2022; 13:1028846.
PMID: 36479211
PMC: 9720316.
DOI: 10.3389/fendo.2022.1028846.
Anthocyanin-rich extract from black beans exerts anti-diabetic effects in rats through a multi-genomic mode of action in adipose tissue.
Damian-Medina K, Milenkovic D, Salinas-Moreno Y, Corral-Jara K, Figueroa-Yanez L, Marino-Marmolejo E
Front Nutr. 2022; 9:1019259.
PMID: 36451736
PMC: 9702351.
DOI: 10.3389/fnut.2022.1019259.
Circulating salivary and serum miRNA-182, 320a, 375 and 503 expression levels in type 2 diabetes.
Khazaei Monfared Y, Honardoost M, Cea M, Gholami S, Mirzaei-Dizgah I, Hashemipour S
J Diabetes Metab Disord. 2022; 21(2):1469-1478.
PMID: 36404826
PMC: 9672281.
DOI: 10.1007/s40200-022-01082-4.
Identification of distinct circulating microRNAs in acute ischemic stroke patients with type 2 diabetes mellitus.
Toor S, Aldous E, Parray A, Akhtar N, Al-Sarraj Y, Abdelalim E
Front Cardiovasc Med. 2022; 9:1024790.
PMID: 36277770
PMC: 9582656.
DOI: 10.3389/fcvm.2022.1024790.
Role of CD40(L)-TRAF signaling in inflammation and resolution-a double-edged sword.
Strohm L, Ubbens H, Munzel T, Daiber A, Daub S
Front Pharmacol. 2022; 13:995061.
PMID: 36267276
PMC: 9577411.
DOI: 10.3389/fphar.2022.995061.
Therapeutic Potential of miRNAs for Type 2 Diabetes Mellitus: An Overview.
Palihaderu P, Mendis B, Premarathne J, Dias W, Yeap S, Ho W
Epigenet Insights. 2022; 15:25168657221130041.
PMID: 36262691
PMC: 9575458.
DOI: 10.1177/25168657221130041.
The effects of all trans retinoic acid, vitamin D3 and their combination on plasma levels of miRNA-125a-5p, miRNA-34a, and miRNA-126 in an experimental model of diabetes.
Sharifzadeh M, Esmaeili-Bandboni A, Emami M, Naeini F, Zarezadeh M, Hassan Javanbakht M
Avicenna J Phytomed. 2022; 12(1):67-76.
PMID: 35145896
PMC: 8801211.
DOI: 10.22038/AJP.2021.18598.